ScreenerHero

ICCCImmuCell Corporation

NAS · US · Healthcare · Biotechnology · immucell.com
10.06USD-0.69%Mkt Cap: 91.37M $P/E: 143.71

ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap91.37M $
Enterprise Value95.23M $
Revenue (TTM)30.68M $
Gross Profit11.45M $
Net Income (TTM)-1.04M $
Revenue/Share3.389 USD
Last Price10.06 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees73
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)143.71
P/E (Forward)-91.73
PEG—
EV/EBITDA13.51
EV/Revenue3.10
P/S2.99
P/B2.92
EPS (TTM)0.07
EPS (Forward)-0.11
52W Range
4.52073% of range12.10
52W High12.10 USD
52W Low4.520 USD
Profitability
Gross Margin41.40%
Oper. Margin26.93%
EBITDA Margin22.99%
Profit Margin-3.76%
ROE-3.84%
ROA-2.45%
Growth
Revenue Growth11.50%
Earnings Growth259.90%
Cash Flow & Leverage
Operating CF2.48M $
CapEx (TTM)1.25M $
FCF Margin10.05%
FCF Yield3.37%
Net Debt3.59M $
Net Debt/EBITDA0.51
Balance Sheet
Debt/Equity0.49
Current Ratio4.75
Quick Ratio2.65
Book Value/Sh3.455 USD
Cash/Share0.9760 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateJul 25, 1990
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.9.08M
Float6.02M
Insiders32.00%
Institutions20.29%
Short Interest
Short Ratio0.6d
Short % Float0.24%
Short % Out.0.19%
Shares Short17.61K
Short (prev mo.)18.72K
Technical
SMA 5010.52 (-4.4%)
SMA 2007.795 (+29.1%)
Beta0.57
S&P 52W Chg18.16%
Avg Vol (30d)30.09K
Avg Vol (10d)44.84K
Technical Indicators
RSI (14)40.4
MACD-0.1355
MACD Signal0.0235
MACD Hist.-0.1590
BB Upper11.70 USD
BB Middle10.81 USD
BB Lower9.925 USD
BB Width16.40%
ATR (14)0.5032 USD
Vol Ratio (20d)0.38x